Study S002175

Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07767552
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: NOT_YET_RECRUITING
Enrollment: 249
Start: 2026-09-30
Primary completion: 2028-08-30
Lead sponsor: Yanbing Li
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Mazdutide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Proportion of Participants Achieving Normal Glucose Regulation (NGR) at Week 44 [Baseline, 44 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.